$QNT

BHATIA MANISH H purchased $1.2M of QNT

BHATIA MANISH H purchased 20,000 shares of Quantinuum Inc. (QNT) at $60.00 ($1.20M total) on 2026-06-05.

Original reporting
SEC EDGAR · BHATIA MANISH H
Published Jun 8, 2026, 8:30 PM UTC
Analysis
alphai AI DeskAI-generated
Added to alphai Jun 8, 2026, 8:32 PM UTC. Informational, not investment advice.
How this was made
alphai summarizes source reporting and applies a structured AI analysis for relevance, timing, sentiment and ticker impact. Always verify material claims with the original publisher.
alphai market briefInsider activity
Primary signal
$QNT
Bullish
low confidence
Mentioned
$QNT
Relevance
7/10
alphai data visualization · based on SEC EDGAR
Decision brief

The 30-second read

$QNTBullishLow
01

Why it matters

The disclosure adds incremental sentiment information but does not introduce new company fundamentals (no earnings, guidance, contract, or regulatory action).

02

Market read

Traders may treat the filing as a small positive sentiment datapoint, but it is unlikely to drive a major repricing without additional catalysts.

03

What to watch

No 10b5-1 plan is cited, but the article also provides no context on prior trading patterns, option exercises, or whether the director’s compensation/vesting schedule drove the purchase.

Relevance 7/10Novelty 6/10Timing: Filed 2026-06-08 (covers purchase dated 2026-06-05).

Background

The article reports a Quantinuum (QNT) insider ownership change via SEC Form 4 (open-market purchase by a director).

Company-level read

Ticker impact

$QNTBullishLow confidence
Context

Director Manish H. Bhatia bought 20,000 shares of Quantinuum (QNT) for $1.2M via an open-market purchase disclosed on Form 4.

Expected impact

Likely limited near-term impact; any effect would be sentiment-driven and small.

Evidence & confidence

The filing is a Form 4 insider transaction with no accompanying operational/regulatory update; insider buys often have weak standalone price follow-through.

Market effects

No sector read-through; this is a single-company insider transaction without new guidance or product/regulatory developments.

None indicated.

None indicated.

Counterpoint

The buy may reflect diversification or personal liquidity planning rather than a strong forward-looking view; Form 4s are often noisy signals.

Key entities

  • Quantinuum Inc.

    Subject of the Form 4 insider transaction disclosure.

  • BHATIA MANISH H

    Director who purchased 20,000 shares for $1.2M on 2026-06-05.

Related articles

$HONMed

Honeywell (NASDAQ: HON) Q2 2026 profit surges on Quantinuum gain

Honeywell (HON) amended its Q2 2026 report to correct segment backlog presentation. It said Q2 and YTD 2026 net sales rose 4% and 3%. Profit was boosted by a $6,629 million gain from Quantinuum deconsolidation, while backlog rose 12% to $38,008 million. The filing also cites margin pressure, $311 million impairments, and a $241 million debt-extinguishment loss.

$QNTMed

Why Is Quantinuum Stock Surging On Thursday? - Quantinuum (NASDAQ:QNT)

Quantinuum (NASDAQ:QNT) shares rose 6.37% to $54.67 Thursday as traders bought after the stock rebounded from its IPO floor. The company, based in Broomfield, Colorado, said it priced an upsized IPO of 28,000,000 Class A shares at $60 each, raising $1.68 billion in gross proceeds, and it cited ongoing commercialization and customer engagements across multiple sectors.